Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema.

American journal of respiratory and critical care medicine - 1 Oct 2011

Criner Gerard J, Cordova Francis, Sternberg Alice L, Martinez Fernando J

Abstract excerpt

The National Emphysema Treatment Trial (NETT) was a multicenter prospective randomized controlled trial that compared optimal medical treatment, including pulmonary rehabilitation, with optimal medical treatment plus lung volume reduction surgery (LVRS). It was the largest and most complete collection of patient demographic, clinical, physiological, and radiographic data ever compiled in severe emphysema. NETT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Hemodynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pneumonectomy

Share to Pulmonary Disease, Chronic Obstructive

Share to Pulmonary Emphysema

Share to Randomized Controlled Trials as Topic

Share to Respiratory Function Tests

Share to White People

Source

Identifiers

PMID: 21757623
DOI: 10.1164/rccm.201103-0454CI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema.PMID 21757623Read ↗

Natural history and clinical management of emphysema in patients with and without alpha 1-antitrypsin inhibitor deficiency.Semantic proximity Read ↗

Distinguishing Smoking-Related Lung Disease Phenotypes Via Imaging and Molecular Features.Semantic proximity Read ↗

Lung transcriptomics of radiologic emphysema reveal barrier function impairment and macrophage M1-M2 imbalanceSemantic proximity Read ↗

Quantitative Chest Computed Tomography in Chronic Obstructive Pulmonary Disease: Assessing the Role of Emphysema Severity and its Correlation with Clinical Characteristics, Lung Function, and Plasma Levels of VEGF and IL-1βSemantic proximity Read ↗

Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency.Semantic proximity Read ↗

Blood-Based Transcriptomic and Proteomic Biomarkers of EmphysemaSemantic proximity Read ↗

An underrecognized phenotype of pulmonary emphysema with marked pulmonary gas exchange but with mild or moderate airway obstruction.Semantic proximity Read ↗

Subtyping COPD by Using Visual and Quantitative CT Imaging Features.Semantic proximity Read ↗

A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHKSemantic proximity Read ↗

National Emphysema Treatment Trial state of the art: genetics of emphysema.Semantic proximity Read ↗

Pulmonary Rehabilitation, an Update: Clinical Phenotypes and Effect of Comorbidities and Echocardiographic Abnormalities.Semantic proximity Read ↗

Prevalence and clinical correlates of bronchoreversibility in severe emphysema.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.